Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.10.30 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2023. Verfasst von Zhiyan Tao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. Hauptthemen laut MEDLINE: Conjunctivitis, Allergic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
- KeyMed Biosciences Inc, Chengdu, Sichuan Province, China.
Zitieren
APA
Tao, Z., Liu, W., Chen, Q., Zhang, L., She, K., Zhao, G., Liang, L., Chen, X., Yang, Y., Song, Q., & Lu, F. (2023). Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.10.30
Vancouver
Tao Z, Liu W, Chen Q, Zhang L, She K, Zhao G, et al. Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.10.30
BibTeX
@article{Tao2023,
author = {Tao, Zhiyan and Liu, Wei and Chen, Qin and Zhang, Libo and She, Kaiqin and Zhao, Guoqing and Liang, Licong and Chen, Xuhong and Yang, Yiliu and Song, Qin and Lu, Fang},
title = {Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.10.30}
}
EUVIMED